-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

625.O1.6 625. T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological: When Old Meets New in T Cell Lymphomas

Symposia: T Cell, NK Cell, or NK/T Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, Antibody Therapy, Adult, Epidemiology, Lymphomas, Translational Research, Non-Hodgkin lymphoma, Drug development, Clinical Research, Health outcomes research, Chemotherapy, B Cell lymphoma, Health disparities research, T Cell lymphoma, Checkpoint Inhibitor, Diseases, Therapy sequence, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Aggressive lymphoma, Biological therapies, Immunotherapy, Lymphoid Malignancies, Non-Biological therapies, Registries, Monoclonal Antibody Therapy, Study Population, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 9:30 AM-11:00 AM
Ballroom 20CD (San Diego Convention Center)
Moderators:
Niloufer Khan, MD, and Nathan Roberts, MD, University of Virginia
Disclosures:
Khan: Kyowa Kirin: Honoraria; Genentech: Research Funding; ADC Therapeutics: Consultancy.
9:30 AM

Alison Moskowitz, MD1, Nivetha Ganesan, MPH2*, Tiffany Chang, MS2*, Theresa Davey, MMSc, PA-C2*, Helen Hancock, ANP2*, Marcel Smith, NP2*, Alicia Assini, NP2*, Lisa Sarmasti, NP2*, Tayler Miller3*, Angela Gibaldi, RN2*, Jonathan H. Schatz, MD4, Eric D. Jacobsen, MD5, Shamir Geller, MD2*, Patricia Myskowski, MD2*, Anita Kumar, MD6, Jennifer Kimberly Lue, MD1, Lorenzo Falchi, MD2, Robert Stuver, MD1, Paola Ghione, MD, MSEpi2, Zachary D. Epstein-Peterson, MD1, William T. Johnson, DO1, Kimon V Argyropoulos, MD PhD7*, Katherine Lopez7*, Kelly Hannigan8*, Win Su Thet2*, Katie Ksanznak3*, Suviasini Patel2*, Maria Salas2*, Sarima Subzwari2*, Marwah Jihad9*, Ellie Casper, MS, DPT1*, Natasha Galasso2*, Heiko Schoder, MD2*, Ahmet Dogan, MD, PhD2, Santosha A. Vardhana, MD, PhD10 and Steven Horwitz, MD1

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, NY
4Sylvester Comprehensive Cancer Center, University of Miami Miller School Medicine, Miami, FL
5Dana Farber Cancer Institute, Boston, MA
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
7Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NY
9Memorial Sloan Kettering Cancer Center, NEW YORK, NY
10Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

9:45 AM

Evgenii Shumilov1*, Maud Ngoya2*, Philipp Berning, MD1*, Irma Khvedelidze2*, Ben Carpenter, MD3*, Robert Zeiser, MD4, Annoek E. C. Broers, MD5*, Didier Blaise, MD6*, Erfan Nur, MD, PhD7, Stephan Mielke, MD8, Emma Nicholson, MD9*, Christof Scheid, MD10, Laimonas Griškevičius, MD, PhD11*, Georg Lenz1, Peter Dreger12, Anna Sureda Balari, MD, PhD13, Gerald Wulf14*, Bertram Glass, MD15*, Ali Bazarbachi, MD, PhD16 and Norbert Schmitz, MD1*

1Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
2Paris Study Unit, Hôpital Saint-Antoine, European Society for Blood and Marrow Transplantation, Paris, France
3University College London Hospitals NHS Foundation Trust, London, United Kingdom
4University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
5Erasmus MC Cancer Institute, Rotterdam, Netherlands
6Department of Hematology, Programme de Transplantation & Therapie Cellulaire, Marseille, France
7Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
8Department of Laboratory Medicine, Cell Therapy and Allogenic Stem Cell Transplantation (CAST), Karolinska Institute & University Hospital, Stockholm, Sweden
9Royal Marsden NHS Foundation Trust, London, United Kingdom
10Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
11Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
12Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany
13Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain
14Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
15Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
16Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

10:00 AM

Min Jung Koh, MS1*, Jessy Xinyi Han, BS2*, Leora Boussi, MD3, Mark N Sorial, PharmD, RPh4*, Sean M McCabe, BS5*, Luke Peng, BS6*, Shambhavi Singh, MD, PhD7, Ijeoma Julie Eche-Ugwu, PhD8,9*, Judith Gabler, MD10*, Maria J. J. Fernandez Turizo, MD11, Caroline MacVicar, BA5*, Aditya Garg7*, Alexander Disciullo, MD12*, Kusha Chopra, BA5*, Alexandra W Lenart, BA5*, Emmanuel Nwodo7*, Jeffrey A. Barnes, MD, PhD13,14, Min Ji Koh, BA10*, Eliana Miranda, MEd, PhD15*, Carlos Chiattone, MD, PhD16, Robert Stuver, MD17, Steven Horwitz, MD17, Mwanasha H. Merrill, MD18, Eric D. Jacobsen, MD19, Jin Seok Kim, MD, PhD20*, Yu Ri Kim, MD21, Jae Yong Cho, MD, PhD22*, Thomas Eipe, PharmD23*, Tanuja Shet, MBBS, MD, DPB, DNB, DTM24*, Epari Sridhar, MD24*, Alok Shetty, MD, DM25*, Saswata Saha, DM26*, Hasmukh Jain, MD, DM27*, Manju Sengar, MD, DM27, Carrie Van Der Weyden, MBBS (Hons), FRACP, FRCPA28*, H. Miles Prince, MD, MBBS29, Ramzi Hamouche, MD30, Tinatin Muradashvili, MD31*, Francine M. Foss, MD32, Marianna Gentilini, MD33*, Beatrice Casadei, MD34*, Pier Luigi Zinzani, MD35,36, Takeshi Okatani, MD37*, Noriaki Yoshida, MD, PhD38, Sang Eun Yoon, MD39*, Won Seog Kim, MD40*, Girisha Panchoo, MBBS41*, Zainab Mohamed, MBChB, MMed42*, Estelle Verburgh, MBChB, M Med Int, FCPSA, PhD42, Jackielyn Cuenca Alturas, BA43*, Mubarak Al Mansour, MD44*, Josie G Ford, BSc45, Martina Manni, PhD46*, Monica Civallero, PhD47*, Tetiana Skrypets, MD48*, Massimo Federico, MD49, Maria Elena Cabrera, MD50*, Amy Ku, MD, PhD51*, Govind Bhagat, MD52, Helen Ma, MD53, Ahmed Sawas, MD54, Khyati Kariya, PhD10*, Makoto Iwasaki, MD, PhD10, Forum Bhanushali55*, Owen A. O'Connor, MD, PhD56, Enrica Marchi, MD, PhD57, Changyu Shen, PhD58*, Devavrat Shah, PhD2* and Salvia Jain, MD59

1Georgetown University School of Medicine, Arlington, VA
2Massachusetts Institute of Technology, Cambridge, MA
3Department of Medicine; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pharmacy, Massachusetts General Hospital Cancer Center, Boston, MA
5Department of Medicine, Massachusetts General Hospital, Boston, MA
6College of Science, Northeastern University, Boston, MA
7Massachusetts General Hospital, Boston, MA
8Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA
9Beth Israel Deaconess Medical Center, Boston, MA
10Massachusetts General Hospital Cancer Center, Boston, MA
11Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
12Cancer Center, Massachusetts General Hospital, Boston, MA
13Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
14Harvard Medical School, Boston, MA
15University of Campinas (UNICAMP), Hematology and Hemotherapy Center (Hemocentro), Campinas, Brazil
16Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
17Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
18Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
19Dana Farber Cancer Institute, Boston, MA
20Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of (South)
21Division of Hematology, Department of Internal Medicine, Hematology, Gangnam Severance Hospital, Seoul, South Korea
22Department of Medicine, Gangnam Severance Hospital, Yonsei University School of Medicine, Seoul, Korea, Republic of (South)
23Department of Clinical Pharmacology, Tata Memorial Centre, Mumbai, India
24Department of Pathology, Tata Memorial Centre, Mumbai, India
25Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
26Department of Medical Oncology, Tata Memorial Centre, Navi Mumbai, Maharashtra, IND
27Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India
28Department of Hematology, Peter MacCallum Cancer Center, Melbourne, VIC, AUS
29Peter MacCallum Cancer Inst., East Melbourne, VIC, AUS
30Department of Hematology, Yale Cancer Center, New Haven, CT
31Department of Hematology, Yale University, Cliffside Park, NJ
32Yale University School of Medicine, Hamden, CT
33Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy
34IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
35University of Bologna, Istituto Di Ematologia, Bologna, Italy
36Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy
37Hiroshima Red Cross & A-Bomb Survivors Hospital, Hiroshima City, JPN
38Radiation Effects Research Foundation, Hiroshima-Shi, JPN
39Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea, Republic of (South)
40Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
41University of Cape Town and Groote Schuur Hospital, Cape town, South Africa
42University of Cape Town, Cape Town, South Africa
43Department of Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia
44Department of Medicine, King Abdulaziz Medical City, Jeddah, SAU
45Department of Medicine, Massachusetts General Hospital, Farmington, CT
46Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, ITA
47CHIMOMO Department, University of Modena and Reggio Emilia, Modena, ITA
48Hematology Unit, IRCCS Istituto Tumori Giovanni Paolo II, Modena, AL, Italy
49Oncologia Medica, University of Modena and Reggio Emilia, Modena, Italy
50Hematology Department, Hospital del Salvador, Santiago, Chile
51Department of Pathology and Cell BIology, Columbia University Irving Medical Center, New York, NY
52Department of Pathology & Cell Biology, Columbia University, New York, NY
53VA Long Beach Health System, University of California, Irvine, Long Beach, CA
54Lymphoma Program, Division of Hematology & Oncology, Columbia University Irving Medical Center, New York
55Brigham and Women's Hospital, Boston, MA
56Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA
57Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA
58Biogen, Cambridge, MA
59Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, MA

10:15 AM

Martine Bagot, MD, PhD1*, Youn H. Kim, MD2, Caroline Ram-Wolff, MD1*, Stéphane Dalle, MD, PhD3*, Neha Mehta-Shah, MD4, Auris O Huen, MD, PharmD5*, Brian Poligone, MD, PhD6*, Pier Luigi Zinzani, MD, PhD7, Larisa J Geskin, MD8*, Anne-Bénédicte Duval-Modeste, MD9*, Pablo L Ortiz-Romero, MD, PhD10*, Lubomir Sokol, MD, PhD11, Sherida Woei-A-Jin, MD, PhD12*, Marie Beylot-Barry, MD, PhD13*, Olivier Dereure, MD, PhD14*, Michael S. Khodadoust, MD, PhD15, Maxime Battistella16*, Alejandro A. Gru, MD17*, Hélène Moins-Teisserenc, MD, PhD18*, Julien Viotti19*, Christine Paiva20*, Agnes Boyer Chammard21* and Pierluigi Porcu22

1Department of Dermatology, Hopital Saint Louis, Université Paris Cité, Inserm U976, Paris, France
2Departments of Dermatology and Medicine - Oncology, Stanford University School of Medicine, Stanford, CA
3Department of Dermatology, Hospices Civils de Lyon, Pierre Bénite, France
4Siteman Cancer Center, Washington University School of Medicine, Olivette, MO
5Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Rochester Skin Lymphoma Medical Group, PLLC, Fairport
7University of Bologna, Bologna, Italy
8Department of Dermatology, Columbia University Irving Medical Center, New York, NY
9Department of Dermatology, CHU de Rouen, Hôpital Charles-Nicolle, Rouen, France
10Department of Dermatology, Hospital 12 de Octubre Medical School, Complutense University of Madrid, Madrid, Spain
11Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
12Department of General Medical Oncology, Universitair Ziekenhuis Leuven, Leuven, Belgium
13Department of Dermatology, Centre Hospitalier Universitaire de Bordeaux – Inserm 1312, Bordeaux, France
14Department of Dermatology, CHU Montpellier, Université Montpellier I, Montpellier, France
15Department of Dermatology, Stanford University, Palo Alto, CA
16Department of Pathology, Saint-Louis Hospital, Paris, France
17Dermatopathology Section, Columbia University Irving Medical Center, New York
18Hematology Laboratory, Hopital Saint-Louis, AP-HP, Université Paris Cité, INSERM 1160, Paris, France
19Innate Pharma, Marseille, France
20Innate-Pharma, Marseille, France
21Innate-Pharma, MARSEILLE, France
22Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA

10:30 AM

Steven Horwitz, MD1, Salvia Jain, MD2, Jacob D. Soumerai, MD3, Michael T. Tees, MD, MPH4, Robert Stuver, MD1, Amro Ali, PharmD5*, Leah Leahy, BS5*, Riadh Lobbardi, PhD5*, Rong Chu, PhD5*, Eunju Hurh, PhD5*, Anthony S. Fiorino, MD, PhD5* and Neha Mehta-Shah, MD6

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Massachusetts General Hospital, Boston, MA
3Center for Lymphoma, Massachusetts General Hospital Cancer Center, Boston, MA
4Colorado Blood Cancer Institute/Sarah Cannon Research Institute, Denver, CO
5C4 Therapeutics, Watertown, MA
6Siteman Cancer Center, Washington University School of Medicine, Olivette, MO

10:45 AM

Christiane Querfeld, MD, PhD1,2, Lu Chen, PhD3*, Xiwei Wu, PhD, MD3*, Zhen Han, PhD, MD4*, ChingYu Su, BS5*, Melissa Banez, CCR6*, Jeralyn Quach, CRN6*, Tiffanie Barnhizer, CRN6*, Liliana Crisan, MD7*, Steven T. Rosen, MD8 and Jasmine Zain, MD9

1Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
2Depts of Pathology & Dermatology, City of Hope and Beckman Research Institute, Duarte, CA
3Department of Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
4Department of Pathology, Beckman Research Institute, City of Hope National Medical Center, Beckman Rese, Duarte, CA
5City of Hope National Medical Center, Beckman Research Institute, Duarte, CA
6Clinical Trials Office, City of Hope National Medical Center, Duarte, CA
7Department of Pathology, Division of Dermatology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
8Department of Hematology and Hematopoietic Cell Transplantation, Beckman Research Institute, City of Hope, Duarte, CA
9City of Hope, Duarte, CA

*signifies non-member of ASH